Literature DB >> 17541335

Screening by anti-endomysium antibodies for celiac disease in Tunisian children with type 1 diabetes mellitus.

Amani Mankaï1, Hechmi Ben Hamouda, Fethi Amri, Leila Ghedira-Besbes, Abdelaziz Harbi, Mohamed Tahar Sfar, Ahmed Sahloul Essoussi, Moncef Jeddi, Ibtissem Ghedira.   

Abstract

AIM: Celiac disease (CD) and type 1 diabetes mellitus (DM1) can frequently coexist, presumably due to a common genetic predisposition. The present study was designed to evaluate the frequency of CD among Tunisian children with DM1. PATIENTS AND METHODS: A total of 205 diabetic children (92 girls, 113 boys, age range 6 months-15 years, median 11 years) were screened for CD by determination of IgA anti-endomysium antibodies (EMA).
RESULTS: EMA were positive in 17 out of 205 (8.3%) children with DM1. The median age of DM1 at onset was significantly lower in patients with EMA than those without EMA (P<10(-7)). In 13 of 17 EMA-positive patients, duodenal biopsy could be performed and a destructive type of CD was confirmed in 11 of them: 8 patients showed total villous atrophy, 3 patients showed a partial villous atrophy. The other two patients showed a normal histological picture with normal number of intraepithelial lymphocytes. Parents of the remaining EMA-positive children refused endoscopy. Thus the prevalence of biopsy-proven CD was 5.3% (11/205). It was 7.6% (7/92) in girls and 3.5% (4/113) in boys but the difference was not statistically significant. Seventy three percent of patients with CD were asymptomatic.
CONCLUSIONS: The prevalence of clinically unrecognized CD, found by EMA screening, is high in Tunisian children with DM1. We suggest that children with diabetes should be screened for CD.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17541335     DOI: 10.1016/s0399-8320(07)89413-9

Source DB:  PubMed          Journal:  Gastroenterol Clin Biol        ISSN: 0399-8320


  8 in total

1.  Anti-Saccharomyces cerevisiae antibodies are frequent in type 1 diabetes.

Authors:  Wahiba Sakly; Amani Mankaï; Nabil Sakly; Yosra Thabet; Achouak Achour; Leila Ghedira-Besbes; Moncef Jeddi; Ibtissem Ghedira
Journal:  Endocr Pathol       Date:  2010-06       Impact factor: 3.943

2.  Prevalence of celiac disease in omani children with type 1 diabetes mellitus: a cross sectional study.

Authors:  Siham Al-Sinani; Sharef Waadallah Sharef; Saif Al-Yaarubi; Ibrahim Al-Zakwani; Khalid Al-Naamani; Aisha Al-Hajri; Said Al-Hasani
Journal:  Oman Med J       Date:  2013-07

3.  Celiac disease and pediatric type 1 diabetes: diagnostic and treatment dilemmas.

Authors:  Shama Sud; Margaret Marcon; Esther Assor; Mark R Palmert; Denis Daneman; Farid H Mahmud
Journal:  Int J Pediatr Endocrinol       Date:  2010-06-23

Review 4.  Coexistence of coeliac disease and type 1 diabetes.

Authors:  Anna Szaflarska-Popławska
Journal:  Prz Gastroenterol       Date:  2014-03-01

5.  [Serological tests for celiac disease in Moroccan patients with type 1 diabetes].

Authors:  Asmaa Drissi Bourhanbour; Sanae Ouadghiri; Nadia Benseffaj; Malika Essakalli
Journal:  Pan Afr Med J       Date:  2016-05-31

6.  The Prevalence of Celiac Disease-Specific Auto-Antibodies in Type 1 Diabetes in a Moroccan Population.

Authors:  Ider Oujamaa; Majda Sebbani; Lahcen Elmoumou; Aïcha Bourrahouate; Rabiy El Qadiry; Soufian El Moussaoui; Imane Ait Sab; Mohamed Sbihi; Laila Ennazk; Ghizlane El Mghari-Tabib; Nawal El Ansari; Hicham Baizri; Mohamed Amine; Brahim Admou
Journal:  Int J Endocrinol       Date:  2019-09-19       Impact factor: 3.257

7.  Celiac disease in type 1 diabetes mellitus in the Kingdom of Saudi Arabia. Characterization and meta-analysis.

Authors:  Mohammad Ayman Safi
Journal:  Saudi Med J       Date:  2019-07       Impact factor: 1.484

8.  High prevalence of celiac disease among Saudi children with type 1 diabetes: a prospective cross-sectional study.

Authors:  Abdulrahman Al-Hussaini; Nimer Sulaiman; Musa Al-Zahrani; Ahmed Alenizi; Imad El Haj
Journal:  BMC Gastroenterol       Date:  2012-12-23       Impact factor: 3.067

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.